BRCA1 and colorectal cancer: In support of this dominant-negative mechanism, additional data in colorectal cancer cells show that exogenous overexpression of BARD1β increases cytoplasmic retention of BRCA1, impairs HR, and sensitizes cells to PARPis by disrupting nuclear BRCA1 function [98].